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Objective: To retrospectively evaluate the frequency and risk factors for developing thrombus in a systemic vein such as 
the infrarenal inferior vena cava or the iliac vein, in which a balloon-occluded retrograde transvenous obliteration (B-RTO) 
catheter was indwelled.
Materials and Methods: Forty-nine patients who underwent B-RTO for gastric varices were included in this study. The 
B-RTO procedure was performed from the right femoral vein, and the B-RTO catheter was retained overnight in all patients. 
Pre- and post-procedural CT scans were retrospectively compared in order to evaluate the development of thrombus in the 
systemic vein in which the catheter was indwelled. Additionally, several variables were analyzed to assess risk factors for 
thrombus in a systemic vein.
Results: In all 49 patients (100%), B-RTO was technically successful, and in 46 patients (94%), complete thrombosis of 
the gastric varices was achieved. In 6 patients (12%), thrombus developed in the infrarenal inferior vena cava or the right 
common-external iliac vein. All thrombi lay longitudinally on the right side of the inferior vena cava or the right iliac vein. 
One of the aforementioned 6 patients required anticoagulation therapy. No symptoms suggestive of pulmonary embolism 
were observed. Prothrombin time-international normalized ratio and the addition of 5% ethanolamine oleate iopamidol, on 
the second day, were related to the development of thrombus. 
Conclusion: Development of a thrombus in a systemic vein such as the inferior vena cava or iliac vein, caused by indwelling 
of the B-RTO catheter, is relatively frequent. Physicians should be aware of the possibility of pulmonary embolism due to 
iliocaval thrombosis.
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INTRODUCTION
Gastric varices are a complication of portal hypertension 
(1-3), though they are less common than esophageal 
varices (1). However, once gastric varices bleed, mortality 
rate without treatment is high: 45-55% (1, 4, 5). Thus, 
immediate management of bleeding gastric varices is 
necessary.
Balloon-occluded retrograde transvenous obliteration 
(B-RTO) is known to be an effective therapy for gastric 
varices caused by portal hypertension, if a dilated Korean J Radiol 13(3), May/Jun 2012 kjronline.org 325
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gastrorenal shunt exists (6-8). Disappearance or regression 
of gastric varices, after B-RTO, can be achieved at a high 
rate, ranging from 90-100%, according to previous reports 
(5-10). However, short-term complications of B-RTO have 
been reported (5, 7, 8, 10-16). Development of thrombosis 
in the left renal vein, main portal veins, superior mesenteric 
veins, and splenic veins are potential complications (11). 
In daily clinical work, we experienced a case in which 
thrombosis developed after B-RTO in the infrarenal inferior 
vena cava and right common-external iliac vein into which 
the B-RTO catheter was inserted. The cause was presumed 
to be the indwelling catheter that had been left in place 
overnight, according to our procedure. To our knowledge, 
there have been no investigations into the development 
of thrombosis in a major systemic vein other than renal 
veins such as the infrarenal inferior vena cava and iliac 
vein. Therefore, we retrospectively evaluated the frequency 
and risk factors for the development of thrombus in the 
systemic vein, in which the catheter was indwelled with the 
exception of the left renal vein, in which a thrombus may 
extend from the gastrorenal shunt.
MATERIALS AND METHODS
Patients
Between June 2004 and September 2010, 52 patients 
underwent B-RTO for gastric varices with a gastrorenal 
shunt which occurred after portal hypertension in 
institutions within our hospital system. In all patients, 
endoscopy revealed active bleeding (spurting or oozing) 
(n = 3) or showed signs of recent bleeding and/or growing 
gastric varices during the observation period (n = 49). 
We investigated data on the 49 patients (24 men and 25 
women; mean age, 65 years; age range, 40-82 years) who 
underwent computed tomography (CT) after B-RTO. Causes 
of their liver cirrhosis were hepatitis B (n = 5), hepatitis C 
(n = 28), chronic alcohol ingestion (n = 12), and others (n 
= 4). According to the Child-Pugh classification, 23 patients 
were in class A, 22 in class B, and 4 in class C. The mean 
Child-Pugh score of the patient group was 6.8 ± 1.6. Of the 
49 patients, 12 had concomitant hepatocellular carcinoma 
(HCC).
B-RTO Procedures
The procedure was performed by one of five interventional 
radiologists in our hospital system; these individuals had 
extensive experience with the B-RTO procedure. These 
institutions did not require institutional review board 
approval for this type of clinical observational study. 
Principles of the Declaration of Helsinki were followed, and 
informedconsent was obtained from all patients.
We performed B-RTO according to the method described 
by Kanagawa et al. (6). Briefly, after an 8-F curved catheter 
sheath-introducer (Medikit, Tokyo, Japan; Terumo Clinical 
Supply, Gifu, Japan) was inserted from the right femoral 
vein to the left renal vein, with the patient under local 
anesthesia, a 6.5-F balloon catheter with a balloon 22 
mm in diameter (Artec Balloon catheter, Create Medics, 
Yokohama, Kanagawa, Japan) or a 6-F balloon catheter with 
a balloon 20 mm in diameter (Selecon balloon catheter, 
Terumo Clinical Supply, Gifu, Japan; Moiyan, Miyano Medical 
Instruments, Hyogo, Japan) was advanced to the left renal 
vein through the sheath-introducer. In 3 of the 49 cases, 
the 8-F sheath-introducer (Medikit) was inserted into the 
inferior vena cava, after which the balloon catheter was 
advanced from the inferior vena cava to the left renal 
vein. After insertion of the balloon catheter, the tip was 
wedged into the end of the gastrorenal shunt. The balloon 
was inflated in order to occlude the gastrorenal shunt. 
Retrograde venography was performed in order to identify 
gastric varices and their inflowing and outflowing vessels 
and to evaluate the degree of outflowing vessels other than 
the gastrorenal shunt. 
If collateral veins other than the gastrorenal shunt were 
visualized, they were embolized with various combinations 
of microcoils, 50% glucose solution, and/or a small 
amount (5%) ethanolamine oleate iopamidol (EOI) (Grelan 
Pharmaceutical, Tokyo, Japan). Retrograde venography 
was performed in order to determine whether the entire 
varix was revealed and whether the outflowing vessels had 
disappeared or decreased. Then, the sclerosing agent, 50% 
glucose solution and/or 5% EOI, was slowly administered 
from the balloon catheter in order to fill the entire gastric 
varix while the balloon was inflated. The procedure was 
determined to be a technical success if the entire gastric 
varix was shown to be filled with the sclerosing agent on 
the fluoroscopic image. The entire setup was left in place 
overnight. If the retrograde venography performed the 
following morning indicated incomplete thrombosis of 
the varices, the sclerosing agent was added (n = 35). An 
incomplete thrombosis was declared even if only a tiny 
part of the gastric varix was stained densely. The sclerosing 
agent was left from 30 minutes to 4 hours, after which it 
was aspirated. The balloon was deflated and the balloon Korean J Radiol 13(3), May/Jun 2012 kjronline.org 326
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catheter was withdrawn. During these procedures, 4000 
units of human haptoglobin were administered intravenously 
in order to prevent renal failure owing to hemolysis. Details 
of the B-RTO procedure have been described elsewhere (17). 
CT Imaging and Evaluation
A contrast-enhanced abdominal multi-detector row 
computed tomography (MDCT) was performed before 
B-RTO, as well as 5 to 15 days (mean 7.3 days) after 
B-RTO, to assess the thrombosis of the gastric varices and 
to determine the presence of complications, including a 
thrombus in a systemic vein. The MDCT unit used for this 
evaluation was either a 64-detector row CT (Brilliance 
64, Philips Medical Systems, Cleveland, OH, USA) or a 
16-detector row CT (Aquillion 16, Toshiba Medical Systems, 
Tokyo, Japan). Non-ionic iodinated contrast material was 
injected via an antecubital vein. The injection duration was 
set at 25 to 30 seconds, and doses of contrast material, 
tailored according to patients’ body weights, were fixed at 
500 to 600 mg I/kg. Scan acquisition for the first phase 
image was obtained with a 15-second delay after the 
automatic scan was triggered by contrast enhancement (170 
HU) in the aorta at the bifurcation of the celiac artery. 
Scan acquisition for the second phase image was obtained 
with a 120- to 135-seconds delay after injection of contrast 
material was completed. Contiguous transaxial images, with 
1 mm (n = 38) and/or 5 mm (n = 49) thickness without 
gaps, were reconstructed from the volumetric data set on 
each MDCT. In 37 of the 49 patients, the CT scans were 
obtained in a craniocaudal direction from the top of the 
liver to the level of the lower pole of the kidney. In the 
remaining 12 patients, CT scans were obtained to the level 
of the inferior border of the pubis. Images reconstructed 
with a width of 5 mm and, if necessary, with a width of 
1 mm, were evaluated. For the present report, pre- and 
postprocedural CT scans were retrospectively compared 
by two radiologists who paid special attention to the 
development of thrombus in the systemic veins in which 
the catheter was indwelled; these veins were the infrarenal 
inferior vena cava, right iliac vein and/or right common 
femoral vein. In addition, the development of thrombus 
in the suprarenal inferior vena cava, the right renal vein, 
the left iliac vein and/or the left common femoral vein 
were evaluated. Thrombus in the left renal vein, in which 
a thrombus may extend from the gastrorenal shunt, was 
not evaluated. Decisions were reached through consensus 
between the two radiologists. 
Investigated Parameters
Issues investigated were 1) incidence of the development 
of thrombus in the systemic veins evaluated, 2) location of 
thrombosis in these veins, and 3) risk factors for thrombosis 
developing in these veins. The variables analyzed in order 
to determine risk factors for thrombosis in system veins 
were: age, sex, Child-Pugh score, presence of HCC, platelet 
count before B-RTO, prothrombin time-international 
normalized ratio (PT-INR) before B-RTO, grade of gastric 
varices according to Hirota et al. (8), amount of 5% EOI 
used, addition of 5% EOI on the second day, duration of 
indwelling of the catheter, tortuosity of the inferior vena 
cava, and the distance between the left adrenal vein and 
the junction of the left renal vein and the inferior vena 
cava. Tortuosity of the inferior vena cava, and distance 
between the left adrenal vein, and the junction of the left 
renal vein and the inferior vena cava were evaluated by 
multiplanar reconstruction images. Tortuosity was thought 
to be present if the inferior vena cava was angulated to 
more than 25 degrees on the coronal image of contrast-
enhanced abdominal MDCT. 
Statistical Analysis
For statistical analysis, commercial software (JMP 5.1; 
SAS Japan, Tokyo, Japan) was used. All variables were 
compared using the Fisher’s exact test if the characteristics 
were qualitative and by the Wilcoxon rank-sum test if 
characteristics were quantitative. 
A p value of less than 0.05 was considered to indicate a 
statistically significant difference for all analyses. 
RESULTS
In all 49 patients (100%), B-RTO was technically 
successful, and in 46 of the 49 patients (93.9%), complete 
thrombosis of the varices was observed on the contrast-
enhanced CT scans obtained 5 to 15 days after B-RTO. B-RTO 
was repeated in 1 of the 3 patients in whom thrombosis 
was incomplete. Reduction of the varices was seen in 
the remaining 2 patients on follow-up CT images and/or 
endoscopy. The total dose of 5% EOI injected ranged from 
6-80 mL (mean dose, 32 mL). The mean dose of 5% EOI 
injected on the first day was 23 mL (range, 5-40 mL), and 
the mean dose of 5% EOI added on the second day was 9 
mL (range, 0-40 mL). 
In 6 of the 49 patients (12.2%), a thrombus developed 
in the infrarenal inferior vena cava and/or the right Korean J Radiol 13(3), May/Jun 2012 kjronline.org 327
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A
C
E
B
D
Fig. 1. 58-year-old man with gastric varices. Balloon-occluded retrograde transvenous obliteration (B-RTO) was performed by 
injecting 20 mL 5% ethanolamine oleate iopamidol (Patient no. 6 in Table 1).
A. Roentgenogram obtained after injection of sclerotic agent showed complete filling by sclerotic agent in gastric varix (arrowhead), curved 
catheter sheath-introducer inserted to left renal vein (large arrow), and balloon catheter wedged into gastrorenal shunt (small arrow). B. 
Roentgenogram obtained day following injection of sclerotic agent showed complete thrombosis of varices (arrowhead). Note that sheath-
introducer in inferior vena cava is seen (arrows). C-E. Enhanced CT obtained 6 days after B-RTO shows thrombus in infrarenal inferior vena cava 
and right common-external iliac vein lying longitudinally on right side of vessel wall (arrows).Korean J Radiol 13(3), May/Jun 2012 kjronline.org 328
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common-external iliac vein (Figs. 1, 2). In these patients, 
the thrombus was located in a systemic vein into which 
the B-RTO catheter had been inserted, while no thrombus 
was observed in the systemic veins into which the B-RTO 
catheter had not been inserted. One of the 6 patients with 
thrombus needed anticoagulation therapy with warfarin 
(Warfarin; Eizai, Tokyo, Japan) because the thrombus was 
relatively large and almost occlusive in the iliac vein. A 
decrease in the thrombus was confirmed by a contrast-
enhanced abdominal CT performed 40 days after B-RTO. 
Table 1 shows details of the 6 patients who developed 
thrombus; none had a history of thrombotic disease. Table 
2 shows results of the analysis of the relationships between 
the development of thrombus in the systemic vein and the 
investigated variables. In those patients with thrombus 
development, PT-INR was significantly lower than in the 
group without thrombus development (p = 0.005). Also, the 
requirement for the addition of 5% EOI on the second day 
was significantly lower (p = 0.048) in the group with the 
development of thrombus. 
Among the 49 patients, complications other than the 
development of thrombus in the inferior vena cava or the 
right common-external iliac vein included migration of a 
microcoil used for the embolization of the inferior phrenic 
vein in 1 patient, stress cardiomyopathy in another, and 
a thrombus in the splenic vein or the portal vein in three. 
Decrease in hepatic and renal function was not observed, 
and none of the patients exhibited symptoms suggestive of 
pulmonary embolism (including the 6 patients in whom a 
thrombus developed in the infrarenal inferior vena cava or 
the right common-external iliac vein).
DISCUSSION
Balloon-occluded retrograde transvenous obliteration 
has become widely accepted as a treatment for gastric 
varices with a gastrorenal shunt (5-17) as its safety 
and effectiveness were reported by Kanagawa et al. (6). 
However, there have been many reports of complications 
of B-RTO, such as hematuria, fever, abdominal pain, pleural 
effusion, and ascites (5, 7, 10, 11, 13-15). Among severe 
complications of B-RTO, development of thrombus in the 
left renal vein, splenic vein, and portal vein were reported 
by Cho et al. (11) to be 15%. Pulmonary embolism, which 
was very rare and ranged from 1.5-4.3% (10, 13, 15), was 
also reported. Shimoda et al. (10) mentioned the cause 
A B
Fig. 2. 45-year-old woman with gastric varices. Balloon-occluded retrograde transvenous obliteration (B-RTO) was performed by 
injecting 15 mL 5% ethanolamine oleate iopamidol (Patient no. 5 in Table 1).
A, B. Enhanced CT obtained 6 days after B-RTO shows thrombus in infrarenal inferior vena cava lying longitudinally on right anterior side of 
vessel wall (arrows).Korean J Radiol 13(3), May/Jun 2012 kjronline.org 329
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a of pulmonary embolism to be a flow of the sclerosant or 
fragments of blood clots into the pulmonary artery from 
a gastrorenal shunt or gastrocaval shunt after balloon 
deflation. However, we are unaware of reports on the 
development of thrombosis, in a major systemic vein such 
as the inferior vena cava and the iliac vein, caused by an 
indwelled catheter for B-RTO. 
Our current analysis showed that, in 6 of 49 patients 
(12.2%), a thrombus developed in the infrarenal inferior 
vena cava or right common-external iliac vein. All of these 
thrombi laid longitudinally on the right side of the inferior 
vena cava and the right iliac vein, which suggests that the 
thrombus originated between the B-RTO catheter and the 
vessel wall. On the other hand, no thrombi developed in 
the systemic veins into which the B-RTO catheter was not 
inserted. This suggests that the development of the thrombi 
was iatrogenic. Although in the majority of these 6 patients, 
the thrombus was so slight that treatment was unnecessary, 
the incidence rate of thrombus (12.2%) was relatively high. 
We should note that most of the patients (37/49 patients) 
did not undergo a CT scan below the kidney; therefore, the 
frequency rate of thrombus might have actually been higher 
than could be determined from our retrospective review 
of the postprocedural CT scans. Although none of these 
patients experienced respiratory symptoms, the presence 
of such a thrombus could lead to pulmonary embolism, 
which would have clinical implications for the care of such 
patients. 
Our results indicated that a lower PT-INR was a risk factor 
for the development of thrombosis. Moreover, in patients 
with thrombus development, the addition of 5% EOI, on the 
second day, was not frequently needed. Additionally, among 
our patients, the rate of incomplete thrombosis detected on 
the second day was relatively higher (35/49 [71%]) than 
the rate reported in previous works, in which the catheter 
was retained for fewer than 3 hours; these reported rates 
ranged from 0% to 45% (5, 7, 8, 10, 12). A potential reason 
for this high rate might be that we assigned the designation 
of incomplete thrombosis even if only a tiny part of 
the gastric varix was stained densely on the retrograde 
venography. In the original report of B-RTO, by Kanagawa et 
al. (6), the B-RTO catheter was withdrawn after 30 minutes. 
However, in more recent reports, the B-RTO catheter 
was retained overnight in order to avoid incomplete 
therapeutic efficacy and pulmonary embolism due to an 
unstable thrombus (13-16). In our study, the duration of 
indwelling of a catheter had no significant connection to Korean J Radiol 13(3), May/Jun 2012 kjronline.org 330
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the development of a thrombus. However, as the catheter 
was left overnight for in patients, differences in duration of 
indwelling of the catheter were too slight to conclude that 
duration did not influence thrombus development. Hence, 
for patients without prolonged coagulation time, retention 
of a B-RTO catheter for a shorter period than an entire 
night might be adequate in the efforts to avoid a thrombus 
in a systemic vein in contact with the B-RTO catheter.
This study had several limitations, such as the small 
number of cases and nearly identical duration of catheter 
indwelling between the groups. In the future, studies should 
be undertaken in order to determine adequate duration of 
B-RTO catheter retention with a larger number of subjects. 
In our study, the frequency of development of a thrombus 
after B-RTO, in a systemic vein such as the inferior vena 
cava or the iliac vein, was relatively high. This indicates 
that physicians should be aware of the possibility of 
pulmonary embolism caused by a thrombus along the B-RTO 
catheter in the inferior vena cava or the iliac vein. 
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